Pulmocide recently completed a Phase 2 safety and tolerability clinical trial (OPERA-S study) in lung transplant patients receiving inhaled opelconazole monotherapy as prophylaxis against pulmonary ...

Pulmonologists expecting to see an increase in individuals with respiratory issues due to the ongoing fires in Los Angeles County have added time for patients to their clinic schedules, Cedars-Sinai ...

For individuals with chronic lung conditions, the winter season and the current cold snap poses significant challenges. We ...

In a cohort of adults with chronic obstructive pulmonary disease (COPD), receiving fluticasone-umeclidinium-vilanterol was ...

For the past 10 years, medications and inhalers began to help less and less with Rose Walsh’s breathing problems. Battling ...

But Verona is off to a strong start as Ohtuvayre generated sales of $42 million in 2024, the company reported on Tuesday.

A study compares budesonide-glycopyrrolate-formoterol and fluticasone-umeclidinium-vilanterol, revealing insights on COPD ...

For patients with chronic obstructive pulmonary disease (COPD), budesonide-glycopyrrolate-formoterol does not improve ...

Metered-dose inhaler budesonide-glycopyrrolate-formoterol (Breztri Aerosphere) was associated with a higher risk of a first ...

ABU DHABI - The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the emirate, has introduced a groundbreaking medication for patients with Pulmonary Arterial ...

Inhaled asthma medications. Univeristy of North Carolina School of Medicine ... Drug treatments for asthma and chronic obstructive pulmonary disease that do not use chlorofluorocarbons. American ...